Results 131 to 140 of about 5,120 (192)

Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours. [PDF]

Br J Cancer
Panasci J, Park CL, Tran B, Siu LL.
europepmc   +1 more source

From Molecular Precision to Clinical Practice: A Comprehensive Review of Bispecific and Trispecific Antibodies in Hematologic Malignancies. [PDF]

Int J Mol Sci
Amoozgar B, Bangolo A, Habibi M, Cho C, Goy A.   +4 more
europepmc   +1 more source

Editorial: AntibodyPlus therapeutics in oncology: innovative mechanisms, therapeutic strategies, and clinical advances. [PDF]

Front Oncol
Chen Y, Ren P, Chen H, He M.
europepmc   +1 more source

Case Report: BKV-specific T cells: a fast, safe and potentially effective treatment option for refractory BKV infections in pediatric patients after allogeneic stem cell transplantation. [PDF]

Front Pediatr
Oberwegner S, Hettler SA, Hensen L, Heinz AT, Braun C, Döring M, Lang P.   +6 more
europepmc   +1 more source

Immunotherapy for Cancer: Current Advances and Future Directions. [PDF]

Int J Mol Sci
Saxena T, Zaman S, Dhanda H, Swain SK, Kushwaha N, Kaur M, Kamal R, Zaheer S, Tanwar P, Kumar N, Siraj F, Rishi B, Misra A.   +12 more
europepmc   +1 more source

Exploring the nanobody patent landscape: a focus on BCMA sequences and structural analysis. [PDF]

MAbs
Xu J, Wang Y, Yuan N, Hu G, Hu Y.
europepmc   +1 more source

Bispecific antibody-drug conjugates in cancer: therapeutic-window determinants, tumour-immune interactions, and clinical translation. [PDF]

Front Immunol
Li Y, Li Y, Huang R, San ZQ, Ye JF.
europepmc   +1 more source

CAR-NK cell therapy for hematological malignancies. [PDF]

Blood Adv
Manzar GS, Hasan MF, Moore M, Tiberti S, Basar R, Daher M.   +5 more
europepmc   +1 more source

[Multispecific antibodies].

Postepy higieny i medycyny doswiadczalnej, 1982
openaire   +1 more source